OSL has not received much attention on social media whilst progressing . With recent regulatory approval in switzerland where it can now sell as well as the European Union , UK , Malaysia and New Zealand where it achieved its first sale not long ago . First Sales expected to come from Europe this year . Already submitted HDE application for Bile Duct Cancer in the United States and if successful this is going to be major step forward into the US Market . Decision due this quarter or the next . Well funded with around $ 20 million cash and Directors on market trade of $ 405 000 is also a good sign of confidence .
Ann: OncoSil receives Swiss regulatory approval, page-28
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.99M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.6¢ | 0.6¢ | $1.536K | 256K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 2163512 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 20140788 | 23 |
View Market Depth
| Last trade - 10.06am 03/07/2024 (20 minute delay) ? |
| OSL (ASX) Chart |